Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dipesh Uprety

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|July 6, 2017
Drug Combinations with Transplantation for MyelomaDipesh Uprety
Clinical Lung Cancer|December 28, 2020
CheckMate 743: A Glimmer of Hope for Malignant Pleural MesotheliomaDipesh Uprety
Clinical Lung Cancer|December 15, 2018
Chemo-immunotherapy: The Beginning of a New Era in Lung CancerDipesh Uprety
The Lancet. Oncology|September 6, 2019
Chemoimmunotherapy for stage IV non-small-cell lung cancerDipesh Uprety
Biologics : Targets & Therapy|August 16, 2019
Clinical utility of ramucirumab in non-small-cell lung cancerDipesh Uprety
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 1, 2021
Osimertinib Should Not Yet Be Considered the Standard of Care for EGFR-Mutant NSCLC in the Adjuvant SettingDipesh Uprety
The Lancet. Oncology|December 1, 2022
Pembrolizumab as adjuvant therapy in non-small-cell lung cancerDipesh Uprety
JAMA|September 22, 2023
Maintenance of Certification (MOC)-Benefit vs BurdenDipesh Uprety, Howard Jack West
JACC. Cardiooncology|August 16, 2021
Targeting the Cardiotoxicity of Epidermal Growth Factor Receptor InhibitorsDipesh Uprety, Aaron S Mansfield
Journal of the American Geriatrics Society|April 22, 2016
Racial Differences in Survival of Elderly Adults with Chronic Myeloid Leukemia Before and After the Introduction of Imatinib in the United StatesBinay Kumar Shah, Dipesh Uprety
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|July 6, 2017
Drug Combinations with Transplantation for MyelomaDipesh Uprety
Clinical Lung Cancer|December 28, 2020
CheckMate 743: A Glimmer of Hope for Malignant Pleural MesotheliomaDipesh Uprety
Clinical Lung Cancer|December 15, 2018
Chemo-immunotherapy: The Beginning of a New Era in Lung CancerDipesh Uprety
The Lancet. Oncology|September 6, 2019
Chemoimmunotherapy for stage IV non-small-cell lung cancerDipesh Uprety
Biologics : Targets & Therapy|August 16, 2019
Clinical utility of ramucirumab in non-small-cell lung cancerDipesh Uprety
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 1, 2021
Osimertinib Should Not Yet Be Considered the Standard of Care for EGFR-Mutant NSCLC in the Adjuvant SettingDipesh Uprety
The Lancet. Oncology|December 1, 2022
Pembrolizumab as adjuvant therapy in non-small-cell lung cancerDipesh Uprety
JAMA|September 22, 2023
Maintenance of Certification (MOC)-Benefit vs BurdenDipesh Uprety, Howard Jack West
JACC. Cardiooncology|August 16, 2021
Targeting the Cardiotoxicity of Epidermal Growth Factor Receptor InhibitorsDipesh Uprety, Aaron S Mansfield
Journal of the American Geriatrics Society|April 22, 2016
Racial Differences in Survival of Elderly Adults with Chronic Myeloid Leukemia Before and After the Introduction of Imatinib in the United StatesBinay Kumar Shah, Dipesh Uprety
Pageof 7